InnoCan Pharma Corporation (CSE:INNO)

InnoCan Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6.69	5.01	3.89	4.95	11.05
Cash & Short-Term Investments	6.69	5.01	3.89	4.95	11.05
Cash Growth	33.53%	28.91%	-21.47%	-55.22%	229.30%
Accounts Receivable	0.22	0.25	0.25	0.06	-
Other Receivables	0.72	0.29	0.42	0.18	0.17
Receivables	0.94	0.54	0.67	0.24	0.17
Inventory	2.18	3.32	1.75	1.13	0.51
Prepaid Expenses	0.07	0.07	0.34	0.45	0.72
Other Current Assets	0.55	0.22	0.17	0.1	0.08
Total Current Assets	10.44	9.15	6.8	6.88	12.52
Property, Plant & Equipment	0.09	0.11	0.14	0.1	0.05
Total Assets	10.52	9.26	6.94	6.98	12.58
Accounts Payable	0.24	0.19	0.11	0.1	0.05
Accrued Expenses	0.73	0.48	0.46	0.32	0.43
Current Portion of Leases	-	0.01	0.02	0.01	0
Other Current Liabilities	0.39	1.57	1.95	0.3	3.08
Total Current Liabilities	1.36	2.24	2.54	0.73	3.56
Long-Term Debt	0.93	-	-	-	-
Long-Term Leases	-	-	0.01	0.02	-
Total Liabilities	2.29	2.24	2.55	0.75	3.56
Additional Paid-In Capital	41.63	40.08	37.18	34.77	33.67
Retained Earnings	-36.03	-34.91	-33.07	-28.37	-24.61
Total Common Equity	5.6	5.17	4.1	6.39	9.06
Minority Interest	2.64	1.86	0.28	-0.17	-0.04
Shareholders' Equity	8.24	7.02	4.39	6.23	9.01
Total Liabilities & Equity	10.52	9.26	6.94	6.98	12.58
Total Debt	0.93	0.01	0.03	0.03	0
Net Cash (Debt)	5.76	5	3.85	4.91	11.05
Net Cash Growth	15.19%	29.75%	-21.60%	-55.53%	233.04%
Net Cash Per Share	1.29	1.16	0.97	1.28	3.20
Filing Date Shares Outstanding	4.5	4.48	4.32	3.87	3.82
Total Common Shares Outstanding	4.5	4.46	4.12	3.84	3.82
Working Capital	9.08	6.91	4.26	6.15	8.96
Book Value Per Share	1.24	1.16	1.00	1.66	2.37
Tangible Book Value	5.6	5.17	4.1	6.39	9.06
Tangible Book Value Per Share	1.24	1.16	1.00	1.66	2.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.